Cipla | CIPLA - Ordinary Share Capital


Cipla reported INR807.78M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Arca Biopharma USD 50.17M 1.45M Mar/2026
aTyr Pharma USD 62.99M 46.35M Mar/2026
Bio Path USD 9.34M 100K Mar/2026
Brainstorm Cell Therapeutics USD 11.04M 0 Mar/2026
Capricor Therapeutics USD 57.37M 11.65M Dec/2025
Cara Therapeutics USD 9.38M 2.01K Mar/2026
Cipla INR 807.78M 17K Mar/2026
Dr.Reddys Laboratories INR 833.07M 382K Sep/2026
Immunic USD 120.38M 21.73M Dec/2025
Minerva Neurosciences USD 1000 0 Sep/2024
Nektar Therapeutics USD 29.47M 9.09M Mar/2026
Sun Pharmaceuticals INR 2.4B 0 Mar/2026
TherapeuticsMD USD 11K 0 Sep/2023
UPL INR 844.17M 856K Mar/2026